Skip to main content

Biotech Stocks, ETFs Could Be Due for Second Half Rallies

Biotechnology stocks and the related exchange traded funds are in a prolonged slump, and along the way, calls for rebounds have been plentiful. They’ve also proven inaccurate. No, biotech stocks and ETFs such as the VanEck Vectors Biotech ETF (BBH) won’t be out of favor permanently. Pinpointing...
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.